Berlin, Germany

Klaus-Wolf Von Eickstedt

This inventor holds 4 USPTO granted patents. Top assignee: Kali-Chemie Aktiengesellschaft. Active years: 1976-1977.


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Isernhagen N.B., DE (1976)
  • Berlin, DE (1976 - 1977)

Company Filing History:


Years Active: 1976-1977

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Klaus-Wolf Von Eickstedt: Innovator in Pharmaceutical Chemistry

Introduction

Klaus-Wolf Von Eickstedt is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of sedative compounds with low toxicity. His innovative work has led to the filing of several patents that showcase his expertise and creativity.

Latest Patents

Klaus-Wolf Von Eickstedt holds a total of 4 patents. His latest patents include compounds such as N,[3-(4'-fluorobenzoyl)propyl]-N.sub.2 -(2'-chloro-5'-methylphenoxy)ethyl]p - N.sub.1 -[3-(4'-fluorobenzoyl)-propyl]-N.sub.2 -[2-(2'-chloro-5'-methylphenoxy)ethyl]-piperazine, which are recognized for their sedative properties. Additionally, he has developed amino carbonyl derivatives of benzofurans, which have various applications in pharmaceutical compositions.

Career Highlights

Klaus-Wolf Von Eickstedt is associated with Kali-Chemie Aktiengesellschaft, where he has been instrumental in advancing research and development in pharmaceutical products. His work has not only contributed to the company's portfolio but has also enhanced the understanding of sedative compounds in the medical field.

Collaborations

Throughout his career, Klaus-Wolf has collaborated with esteemed colleagues such as Wolfgang Milkowski and Horst Zeugner. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Klaus-Wolf Von Eickstedt is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important sedative compounds. His contributions continue to impact the field positively, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…